Hypertensive Emergency In UMOD-Related Autosomal Dominant Tubulointerstitial Kidney Disease

Overview

Journal Brown J Hosp Med

Date 2025 Mar 6

PMID 40046804

Authors

Talha Chaudhry

Sunil Sapru

Affiliations

Soon will be listed here.

Abstract

Hypertensive emergency is characterized by an acute elevation in blood pressure with evidence of impending or progressive acute target organ damage. Management relies mainly on intravenous medications guided by the type of target-organ damage, but there is considerable variability in practice regarding the choice of medications and optimal therapy. Such variables include the choice of agent and the blood pressure goal, but also underlying medical conditions. We report a case of hypertensive emergency in a 39-year-old-male with a rare genetic condition, UMOD-related autosomal dominant tubulointerstitial kidney disease which gave rise to adolescent gout, worsening kidney function over decades and treatment-resistant hypertension.

References

Lin Z, Yang J, Liu H, Cai D, An Z, Yu Y . A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review. Ren Fail. 2018; 40(1):146-151. PMC: 6014484. DOI: 10.1080/0886022X.2018.1450757. View

Olinger E, Hofmann P, Kidd K, Dufour I, Belge H, Schaeffer C . Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1. Kidney Int. 2020; 98(3):717-731. DOI: 10.1016/j.kint.2020.04.038. View

Groopman E, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal V, Milo-Rasouly H . Diagnostic Utility of Exome Sequencing for Kidney Disease. N Engl J Med. 2018; 380(2):142-151. PMC: 6510541. DOI: 10.1056/NEJMoa1806891. View

Devuyst O, Bochud M, Olinger E . UMOD and the architecture of kidney disease. Pflugers Arch. 2022; 474(8):771-781. PMC: 9338900. DOI: 10.1007/s00424-022-02733-4. View

Kipp A, Olinger E . What Does Uromodulin Do?. Clin J Am Soc Nephrol. 2020; 16(1):150-153. PMC: 7792635. DOI: 10.2215/CJN.06390420. View

Bleyer A, Wolf M, Kidd K, Zivna M, Kmoch S . Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β. Pediatr Nephrol. 2021; 37(5):933-946. PMC: 8722360. DOI: 10.1007/s00467-021-05118-4. View

Bleyer A, Kidd K, Zivna M, Kmoch S . Autosomal Dominant Tubulointerstitial Kidney Disease. Adv Chronic Kidney Dis. 2017; 24(2):86-93. PMC: 5488707. DOI: 10.1053/j.ackd.2016.11.012. View

Johnson R, Nakagawa T, Jalal D, Sanchez-Lozada L, Kang D, Ritz E . Uric acid and chronic kidney disease: which is chasing which?. Nephrol Dial Transplant. 2013; 28(9):2221-8. PMC: 4318947. DOI: 10.1093/ndt/gft029. View

Sanchez-Lozada L, Rodriguez-Iturbe B, Kelley E, Nakagawa T, Madero M, Feig D . Uric Acid and Hypertension: An Update With Recommendations. Am J Hypertens. 2020; 33(7):583-594. PMC: 7368167. DOI: 10.1093/ajh/hpaa044. View

10.

Eckardt K, Alper S, Antignac C, Bleyer A, Chauveau D, Dahan K . Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report. Kidney Int. 2015; 88(4):676-83. DOI: 10.1038/ki.2015.28. View

11.

Kidd K, Vyletal P, Schaeffer C, Olinger E, Zivna M, Hodanova K . Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to Mutations. Kidney Int Rep. 2020; 5(9):1472-1485. PMC: 7486199. DOI: 10.1016/j.ekir.2020.06.029. View

12.

Peixoto A . Acute Severe Hypertension. N Engl J Med. 2019; 381(19):1843-1852. DOI: 10.1056/NEJMcp1901117. View